Subscribe
Search
Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers
A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities
Bergamo, Italy : 12 - 14 February 2020
Partners and Sponsors
About the Conference
This conference will cover recent developments in cancer research that are crucial to our understanding of the multifaceted role of cell death in tumour initiation, progression and therapy response. The programme is structured to maximise interactions between participants and it will be a strong venue for identifying new techniques and collaborations.
Fast Facts
- 150-200 participants expected
- 100% recommendation rate at the 2018 edition
- Networking sessions available to all exhibitors
- World-class speakers
- Friendly intimate atmosphere
Question about sponsorship?
If you are visiting this site as a potential sponsor or exhibitor please contact:
Caroline Moulins
EACR Communications and Corporate Marketing Officer
caroline.moulins@eacr.org
Premium Sponsor
.png) |
VectorBuilder (Stand 4) |
|
Thursday 13 February 08:45 – 09:00 |
|
 |
|
|
Friday 14 February 08:45 – 09:00 |
Keynote Lecture Sponsor
 |
Grant
 |
Above: Venue floor plan. Have a look below for the Exhibition Floor Plan.
Exhibitor resources
This conference has been certified compliant with the MedTech Europe Code of Ethical Business Practice.
Loyalty Offer
When you book two Classic packages for EACR Conference Series events taking place in one calendar year, any further Classic Packages booked for the same year will receive a 20% discount. This does not apply to the EACR's Industry Partners, who receive 30% off all opportunities.
Sorry. You need to upgrade your browser
You are using Internet Explorer 8
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.
Thank you.
